schizophrenia

FDA accepts Otsuka, Lundbeck filing for long-acting schizophrenia drug, teeing up April decision date
Fierce Pharma
Tue, 09/13/22 - 10:50 am
Otsuka
Lundbeck
schizophrenia
FDA
bipolar disorder
Abilify Maintena
Maplight concludes Phase I trial of schizophrenia and dyskinesia therapy
Clinical Trials Arena
Fri, 08/19/22 - 10:38 am
Maplight Therapeutics
clinical trials
ML-007
schizophrenia
dyskinesia
Karuna’s resurrection of Lilly drug delivers phase 3 schizophrenia success, teeing up 2023 filing
Fierce Biotech
Mon, 08/8/22 - 10:14 am
Karuna Therapeutics
clinical trials
schizophrenia
KarXT
Karuna seeks a novel schizophrenia mechanism
EP Vantage
Thu, 06/23/22 - 10:31 am
Karuna Therapeutics
antipsychotics
schizophrenia
KarXT
Teva receives CRL for reformulated schizophrenia drug developed with French biotech
Endpoints
Wed, 04/20/22 - 10:48 am
Teva Pharmaceutical
MedinCell
schizophrenia
FDA
complete response letter
A Win for AI: FDA Approves BioXCel Therapy for Bipolar Disorder and Schizophrenia
BioSpace
Wed, 04/6/22 - 07:47 pm
BioXcel
artificial intelligence
bipolar disorder
schizophrenia
FDA
Igalmi
With a make-or-break PhIII readout looming, a struggling Concert offloads a 'portfolio' of drugs
Endpoints
Mon, 03/14/22 - 10:31 am
Concert Pharmaceuticals
Terran Biosciences
CNS
schizophrenia
Teva's Risperidone Injectable Wards Off Schizophrenia Relapse in Phase III
BioSpace
Tue, 11/2/21 - 10:55 am
Teva Pharmaceutical
schizophrenia
clinical trials
Risperidone
TV-46000
Johnson & Johnson scores an FDA first with nod for twice-yearly schizophrenia drug Invega Hafyera
Fierce Pharma
Wed, 09/1/21 - 11:16 am
JNJ
FDA
Hafyera
schizophrenia
Pfizer's neuroscience spinout scores in schizophrenia
BioPharma Dive
Wed, 06/30/21 - 12:05 am
Cerevel Therapeutics
Pfizer
schizophrenia
clinical trials
Langer lab spinout Lyndra raises $60.5M in bid to replace existing HIV, schizophrenia, opioid abuse treatments
Endpoints
Thu, 06/24/21 - 11:10 am
Langer
Lyndra
funding
HIV
schizophrenia
opioid abuse
Alkermes prepares for uncertain launch as FDA finally clears schizophrenia drug
Biopharma Dive
Tue, 06/1/21 - 10:37 pm
Alkermes
FDA
schizophrenia
bipolar disorder
Lybalvi
Lyndra Therapeutics' Once-Per-Week Schizophrenia Treatment Shines in Phase II
BioSpace
Mon, 04/19/21 - 10:28 pm
Lyndra Therapeutics
schizophrenia
clinical trials
LYN-005
Safety study pushes back phase 3 trial of Newron’s schizophrenia drug
Pharmaforum
Thu, 04/1/21 - 10:54 am
Newron
schizophrenia
clinical trials
FDA
A closely watched schizophrenia drug fails key test
BioPharma Dive
Tue, 03/2/21 - 11:54 pm
Neurocrine
schizophrenia
Takeda
clinical trials
luvadaxistat
Concert dumps schizophrenia drug CTP-692 after failing phase 2
Fierce Biotech
Mon, 02/1/21 - 10:56 am
Concert Pharmaceuticals
CTP-692
clinical trials
schizophrenia
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia
Pharmaceutical Business Review
Fri, 01/8/21 - 09:24 am
Teva Pharmaceutical
MedinCell
TV-46000
clinical trials
schizophrenia
Alkermes sees swift turnaround for rejected schizophrenia med as FDA accepts resubmission
Fierce Biotech
Tue, 12/29/20 - 10:51 am
Alkermes
ALKS 5461
ALKS 3831
FDA
drug manufacturing
schizophrenia
Minerva stumbles with U.S. application for schizophrenia med; shares down 15%
Seeking Alpha
Tue, 12/1/20 - 11:10 am
Minerva Neurosciences
schizophrenia
FDA
roluperidone
Trial Drug Shows Promise in Treating Cognitive Impairment Associated with Schizophrenia
BioSpace
Tue, 12/1/20 - 11:08 am
Cerevance
CVN058
schizophrenia
clinical trials

Pages